Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data.
作者信息
Sibai Baha M, Rouse Dwight J
机构信息
Dr. Sibai is from the Department of Obstetrics, Gynecology and Reproductive Sciences, UT Health- University of Texas Medical School at Houston, Houston, TX; e-mail:
出版信息
Obstet Gynecol. 2016 Oct;128(4):681-4. doi: 10.1097/AOG.0000000000001656.
Abstract
摘要
相似文献
1
Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data.
Obstet Gynecol. 2016 Oct;128(4):681-4. doi: 10.1097/AOG.0000000000001656.
2
Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data.
Obstet Gynecol. 2017 Feb;129(2):382. doi: 10.1097/AOG.0000000000001873.
3
Re: A comparison of the recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from the major guidelines: Impact on thromboprophylaxis rates of implementing Royal College of Obstetricians and Gynaecologists' guidance for reducing the risk of ante- and postnatal venous thromboembolism.
BJOG. 2017 Apr;124(5):831-832. doi: 10.1111/1471-0528.14001.
4
Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
Health Technol Assess. 2020 Dec;24(69):1-80. doi: 10.3310/hta24690.
5
Peripartum thromboprophylaxis before and after implementation of a uniform heparin protocol.
J Perinat Med. 2014 Mar;42(2):219-23. doi: 10.1515/jpm-2013-0165.
6
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785.
7
Where do we go now with low molecular weight heparin use in obstetric care?
J Thromb Haemost. 2008 Sep;6(9):1461-7. doi: 10.1111/j.1538-7836.2008.03048.x. Epub 2008 Jun 4.
8
Postpartum thromboprophylaxis in a multireligious cohort: a retrospective review of indications and uptake.
J Obstet Gynaecol. 2018 May;38(4):493-497. doi: 10.1080/01443615.2017.1389867. Epub 2018 Feb 12.
9
The prevention of pregnancy-related venous thromboembolism.
Br J Haematol. 2015 Jan;168(2):163-74. doi: 10.1111/bjh.13159. Epub 2014 Oct 14.
10
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Thromb Res. 2016 Aug;144:62-8. doi: 10.1016/j.thromres.2016.06.001. Epub 2016 Jun 3.
引用本文的文献
1
Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.
Am J Obstet Gynecol. 2024 Jul;231(1):128.e1-128.e11. doi: 10.1016/j.ajog.2023.11.013. Epub 2024 Feb 12.
2
Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):559-569. doi: 10.1182/hematology.2021000291.
3
Postpartum Heparin Thromboprophylaxis: More Harm Than Good.
Obstet Gynecol. 2021 Oct 1;138(4):527-529. doi: 10.1097/AOG.0000000000004554.
4
Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.
Thromb Res. 2020 Jul;191:42-49. doi: 10.1016/j.thromres.2020.03.025. Epub 2020 Apr 23.
5
Sequential compression device compliance in pregnant women requiring antepartum admission.
J Matern Fetal Neonatal Med. 2021 Apr;34(7):1063-1069. doi: 10.1080/14767058.2019.1623873. Epub 2019 Jun 4.
6
Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines.
Thromb J. 2018 Oct 10;16:25. doi: 10.1186/s12959-018-0180-6. eCollection 2018.
7
Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens.
BJOG. 2018 Aug;125(9):1109-1116. doi: 10.1111/1471-0528.15150. Epub 2018 Mar 7.
8
Venous Thromboembolism Prophylaxis During Antepartum Admissions and Postpartum Readmissions.
Obstet Gynecol. 2017 Aug;130(2):270-278. doi: 10.1097/AOG.0000000000002099.
9
Implementation of a Risk-Based Heparin Protocol for Postpartum Venous Thromboembolism Prevention.
Obstet Gynecol. 2017 Aug;130(2):262-269. doi: 10.1097/AOG.0000000000002050.
本文引用的文献
1
National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism.
Obstet Gynecol. 2016 Oct;128(4):688-98. doi: 10.1097/AOG.0000000000001579.
2
A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines.
BJOG. 2016 Dec;123(13):2157-2162. doi: 10.1111/1471-0528.13706. Epub 2015 Oct 5.
3
Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification.
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):387-92. doi: 10.1182/asheducation-2014.1.387. Epub 2014 Nov 18.
4
Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage.
Am J Obstet Gynecol. 2014 Jul;211(1):32.e1-9. doi: 10.1016/j.ajog.2014.03.031. Epub 2014 Mar 14.
5
Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
Cochrane Database Syst Rev. 2014 Feb 11(2):CD001689. doi: 10.1002/14651858.CD001689.pub3.
6
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e691S-e736S. doi: 10.1378/chest.11-2300.
7
Practice bulletin no. 123: thromboembolism in pregnancy.
Obstet Gynecol. 2011 Sep;118(3):718-729. doi: 10.1097/AOG.0b013e3182310c4c.
8
Prothrombin gene G20210A mutation and obstetric complications.
Obstet Gynecol. 2010 Jan;115(1):14-20. doi: 10.1097/AOG.0b013e3181c88918.
9
The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
Obstet Gynecol. 2005 Sep;106(3):517-24. doi: 10.1097/01.AOG.0000173986.32528.ca.
10
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.
N Engl J Med. 1988 May 5;318(18):1162-73. doi: 10.1056/NEJM198805053181805.
Zotero 插件